{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:08:10Z","timestamp":1747224490532,"version":"3.40.5"},"reference-count":19,"publisher":"PAGEPress Publications","issue":"4","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatismo"],"abstract":"<jats:p>Neutrophilic myositis (NM) is an inflammatory disorder predominantly characterized by neutrophilic infiltration in the muscles, which is suggested to be an extracutaneous manifestation of neutrophilic dermatosis (ND). NM is a rare disorder which has been occasionally reported in association with hematologic and inflammatory disorders. This case report describes a 45-year-old woman who presented with gradual muscle weakness developed after coronavirus disease 2019 (COVID-19) infection. Electromyography and nerve conduction velocity findings were compatible with inflammatory myopathy and muscle biopsy revealed neutrophilic infiltration. She was successfully treated with intravenous immunoglobulin, prednisolone 1 mg\/kg\/day and azathioprine 150 mg\/day. In conclusion, the COVID-19 infection itself and the drugs used to treat it can cause a number of muscle disorders. Awareness of muscular involvement in COVID-19 infected patients is important for early diagnosis and appropriate treatment.<\/jats:p>","DOI":"10.4081\/reumatismo.2021.1437","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T16:43:24Z","timestamp":1644252204000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment of COVID-19 induced neutrophilic myositis with intravenous immunoglobulin and corticosteroids: a case report"],"prefix":"10.4081","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-492X","authenticated-orcid":false,"given":"S.","family":"Assar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pournazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Soufivand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-3240","authenticated-orcid":false,"given":"D.","family":"Mohamadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"1138","doi-asserted-by":"crossref","unstructured":"Marie I, Levesque H, Joly P, et al. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol. 2001; 44: 137-9.","DOI":"10.1067\/mjd.2001.110903"},{"key":"1139","doi-asserted-by":"crossref","unstructured":"Kim MK, Park JW, Park SH, et al. Neutrophilic myositis without cutaneous involvement as the first manifestation of acute myeloid leukemia. Korean J Intern Med. 200; 20: 346-8.","DOI":"10.3904\/kjim.2005.20.4.346"},{"key":"1140","unstructured":"Christ E, Linka A, Jacky E, et al. Sweet\u2019s syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia. 1996; 10: 731-4."},{"key":"1141","doi-asserted-by":"crossref","unstructured":"Melinkeri SR, Gupta RK, Dabadghao S. A Sweet-like syndrome manifesting as gingival hyperplasia and myositis without cutaneous involvement. Ann Hematol. 2002; 81: 397-8.","DOI":"10.1007\/s00277-002-0470-7"},{"key":"1142","doi-asserted-by":"crossref","unstructured":"Qureshi JA, Staugaitis SM, Calabrese LH. Neutrophilic myositis: an extra-intestinal manifestation of ulcerative colitis. J Clin Rheumatol. 2002; 8: 85-8.","DOI":"10.1097\/00124743-200204000-00004"},{"key":"1143","doi-asserted-by":"crossref","unstructured":"Alawneh K, Ashley C, Carlson JA. Neutrophilic myositis as a manifestation of celiac disease: a case report. Clin Rheumatol. 2008; 27: 11-3.","DOI":"10.1007\/s10067-007-0801-0"},{"key":"1144","doi-asserted-by":"crossref","unstructured":"Mosnier E, Rousset P, Hugol D, et al. Neutrophilic myositis sine dermatitis in a neutropenic patient with myelodysplastic syndrome. Ann Hematol. 2013; 92: 551-2.","DOI":"10.1007\/s00277-012-1599-7"},{"key":"1145","doi-asserted-by":"crossref","unstructured":"Matsui Y, Makino T, Torai R, Shimizu T. Neutrophilic myositis developing in a case of systemic lupus erythematosus. Eur J Dermatol. 2020; 30: 432-433.","DOI":"10.1684\/ejd.2020.3807"},{"key":"1146","doi-asserted-by":"crossref","unstructured":"Parra-Medina R, Sarmiento-Monroy JC, Rojas-Villarraga A, et al. Colchicine as a possible therapeutic option in COVID-19 infection. Clin Rheumatol. 2020; 39: 2485-6.","DOI":"10.1007\/s10067-020-05247-5"},{"key":"1147","doi-asserted-by":"crossref","unstructured":"Balagholi S, Dabbaghi R, Eshghi P, et al. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy. Transfus Apher Sci. 2020; 59: 102993.","DOI":"10.1016\/j.transci.2020.102993"},{"key":"1148","doi-asserted-by":"crossref","unstructured":"Kuncl RW, Duncan G, Watson D, et al. Colchicine myopathy and neuropathy. N Engl J Med. 1987; 316: 1562-8","DOI":"10.1056\/NEJM198706183162502"},{"key":"1149","doi-asserted-by":"crossref","unstructured":"Riggs JE, Schochet SS Jr, Gutmann L, et al. Chronic human colchicine neuropathy and myopathy. Arch Neurol. 1986; 43: 521-3.","DOI":"10.1001\/archneur.1986.00520050091033"},{"key":"1150","doi-asserted-by":"crossref","unstructured":"Uslu S. Myositis due to COVID-19. Postgrad Med J. 2021; 97: 399.","DOI":"10.1136\/postgradmedj-2021-139725"},{"key":"1151","doi-asserted-by":"crossref","unstructured":"Zhang H, Charmchi Z, Seidman RJ, et al. COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020; 62: 57-60.","DOI":"10.1002\/mus.27003"},{"key":"1152","doi-asserted-by":"crossref","unstructured":"Beydon M, Chevalier K, Al Tabaa O, et al. Myositis as a manifestation of SARS-CoV-2. Ann Rheum Dis. 2020; 23: 2020-217573.","DOI":"10.1136\/annrheumdis-2020-217573"},{"key":"1153","doi-asserted-by":"crossref","unstructured":"Leung TW, Wong KS, Hui AC, et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol. 2005; 62: 1113-7.","DOI":"10.1001\/archneur.62.7.1113"},{"key":"1154","doi-asserted-by":"crossref","unstructured":"Manzano GS, Woods JK, Amato AA. Covid-19-associated myopathy caused by type I interferonopathy. N Engl J Med. 2020; 383: 2389-2390.","DOI":"10.1056\/NEJMc2031085"},{"key":"1155","unstructured":"Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol. 2020; 39: 289-301."},{"key":"1156","doi-asserted-by":"crossref","unstructured":"Cohen PR. Sweet\u2019s syndrome - a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007; 2: 34.","DOI":"10.1186\/1750-1172-2-34"}],"container-title":["Reumatismo"],"original-title":[],"link":[{"URL":"https:\/\/www.reumatismo.org\/index.php\/reuma\/article\/download\/1437\/926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.reumatismo.org\/index.php\/reuma\/article\/download\/1437\/926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T16:43:51Z","timestamp":1644252231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.reumatismo.org\/index.php\/reuma\/article\/view\/1437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,31]]}},"URL":"https:\/\/doi.org\/10.4081\/reumatismo.2021.1437","relation":{},"ISSN":["2240-2683","0048-7449"],"issn-type":[{"type":"electronic","value":"2240-2683"},{"type":"print","value":"0048-7449"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}